THE TRUE SCOPE OF NIRSEVIMAB
Nirsevimab is a long-acting monoclonal antibody directed against the F protein of the respiratory syncytial virus (RSV). It contains mutations in its Fc region that allow for an extended half-life, providing protection for more than three months with a single dose[…]
THE TRUE SCOPE OF NIRSEVIMAB Leer más »





